Rybelsus is a prescription medication used primarily to treat type 2 diabetes in adults. Its active ingredient is semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. Unlike most other GLP-1 drugs, Rybelsus is the first and only oral (pill) form of semaglutide approved by the FDA. It is taken once daily as a tablet and works